Editorial: Diabetes and non-alcoholic fatty liver disease: points of physiological and mechanistic intersection and current co-therapeutic approaches

Editorial: Diabetes and non-alcoholic fatty liver disease: points of physiological and mechanistic intersection and current co-therapeutic approaches

Bibliographic Details
Main Authors:	Nick Giannoukakis, Kyle S. McCommis
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-07-01
Series:	Frontiers in Endocrinology
Subjects:	NAFLD NASH diabetes T2D T1D pharmacotherapeutics
Online Access:	https://www.frontiersin.org/articles/10.3389/fendo.2023.1253604/full

Similar Items

Treatment regimens for non-alcoholic fatty liver disease
by: Brian P. Lam, et al.
Published: (2009-01-01)

Epigenome-Wide Association Studies Provide Insight into the Pathogenesis of Non-alcoholic Fatty Liver Disease and Non-alcoholic Steatohepatitis
by: Aybike Birerdinc, et al.
Published: (2018-01-01)

Role of MicroRNAs in Pathophysiology of Non-alcoholic Fatty Liver Disease and Non-alcoholic Steatohepatitis
by: Farzaneh Iravani, et al.
Published: (2018-10-01)

Research progress on the therapeutic effects of polysaccharides on non-alcoholic fatty liver diseases
by: Yu-long Hu, et al.
Published: (2023-03-01)

Diagnostic and therapeutic strategies for non-alcoholic fatty liver disease
by: Yajie Fu, et al.
Published: (2022-11-01)

Editorial: Advances in non-alcoholic fatty liver disease therapeutics: Pathogenic mechanisms and targets
by: Ana Blas-García, et al.
Published: (2022-11-01)

Association of Breastfeeding with Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis in mothers: A cross sectional survey
by: Muhammad Zafar Majeed Babar, et al.
Published: (2024-06-01)

Association of Breastfeeding with Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis in mothers: A cross sectional survey
by: Muhammad Zafar Majeed Babar, et al.
Published: (2024-06-01)

Renal resistive index in non-alcoholic fatty liver disease as an indicator of early renal affection
by: Hossam El-Din A. Mahmoud, et al.
Published: (2020-02-01)

Is there an association between non-alcoholic fatty liver disease and cognitive function? A systematic review
by: Elena S. George, et al.
Published: (2022-01-01)

Associations between perfluoroalkyl substances and the severity of non-alcoholic fatty liver disease
by: Norma David, et al.
Published: (2023-10-01)

Non-invasive assessment of fibrosis in non-alcoholic fatty liver disease (NAFLD)
by: Francesco Vizzutti;, et al.
Published: (2009-04-01)

A Review Of Current And Upcoming Treatment Modalities In Non-Alcoholic Fatty Liver Disease And Non-Alcoholic Steatohepatitis
by: Ganguli S, et al.
Published: (2019-11-01)

Diagnosis and Staging of Pediatric Non-Alcoholic Fatty Liver Disease: Is Classical Ultrasound the Answer?
by: Angeliki Papachristodoulou, et al.
Published: (2021-06-01)

Risk of Non-Alcoholic Fatty Liver Disease in Xanthelasma Palpebrarum
by: Chen HW, et al.
Published: (2021-05-01)

Uncoupling hepatic insulin resistance – hepatic inflammation to improve insulin sensitivity and to prevent impaired metabolism-associated fatty liver disease in type 2 diabetes
by: Sitara Niranjan, et al.
Published: (2023-06-01)

Analysis of Common Pathways and Markers From Non-Alcoholic Fatty Liver Disease to Immune-Mediated Diseases
by: Rocío Gallego-Durán, et al.
Published: (2021-11-01)

Non-alcoholic fatty liver disease and microRNAs expression, how it affects the development and progression of the disease
by: Guillermo Nahúm López-Sánchez, et al.
Published: (2021-03-01)

Inhibiting Ceramide Synthesis Attenuates Hepatic Steatosis and Fibrosis in Rats With Non-alcoholic Fatty Liver Disease
by: Meng Jiang, et al.
Published: (2019-09-01)

Beneficial effect of omarigliptin on diabetic patients with non-alcoholic fatty liver disease/non-alcoholic steatohepatitis
by: Sachiko Hattori, et al.
Published: (2021-03-01)

Nonalcoholic Fatty Liver Disease Progresses into Severe NASH when Physiological Mechanisms of Tissue Homeostasis Collapse
by: Silvia Sookoian, et al.
Published: (2018-03-01)

Metabolic drivers of non-alcoholic fatty liver disease
by: Kendra K. Bence, et al.
Published: (2021-08-01)

A Review of the Therapeutic Potential of Ginseng and Its Bioactive Components in Nonalcoholic Fatty Liver Disease
by: Hao L, et al.
Published: (2025-01-01)

Paraoxonase 1 and Non-Alcoholic Fatty Liver Disease: A Meta-Analysis
by: Kazuhiko Kotani, et al.
Published: (2021-04-01)

Revisiting the Role of Natural Killer Cells in Non-Alcoholic Fatty Liver Disease
by: María Luz Martínez-Chantar, et al.
Published: (2021-02-01)

Macrophages as a source of fibrosis biomarkers for non-alcoholic fatty liver disease
by: Sachiyo Yoshio, et al.
Published: (2021-07-01)

Simultaneous Metabolic and Alcohol-associated Fatty Liver Disease (SMAFLD) and Simultaneous Metabolic and Alcohol-associated Steatohepatitis (SMASH)
by: Nizar H. Senussi, MD, et al.
Published: (2021-09-01)

Nonalcoholic fatty liver disease and its association with cardiovascular disease
by: Javier Lizardi-Cervera, et al.
Published: (2009-01-01)

Screening strategies for non-alcoholic fatty liver disease: a holistic approach is needed
by: Philipp Kasper, et al.
Published: (2023-04-01)

Depression in non-alcoholic fatty liver disease is associated with an increased risk of complications and mortality
by: Cheng Han Ng, et al.
Published: (2022-10-01)

Double Trouble: How Microbiome Dysbiosis and Mitochondrial Dysfunction Drive Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis
by: Wesam Bahitham, et al.
Published: (2024-02-01)

Non-Invasive Diagnostic Test for Advanced Fibrosis in Adolescents With Non-Alcoholic Fatty Liver Disease
by: Antonella Mosca, et al.
Published: (2022-04-01)

Epidemiology and natural history of non-alcoholic fatty liver disease (NAFLD)
by: Stefano Bellentani, et al.
Published: (2009-01-01)

Recent advances in non-invasive diagnosis and medical management of non-alcoholic fatty liver disease in adult
by: Jayanta Paul
Published: (2020-07-01)

Intestinal Barrier Dysfunction and Gut Microbiota in Non-Alcoholic Fatty Liver Disease: Assessment, Mechanisms, and Therapeutic Considerations
by: Changrui Long, et al.
Published: (2024-04-01)

Curcumin and inflammation in non-alcoholic fatty liver disease: a randomized, placebo controlled clinical trial
by: Saeede Saadati, et al.
Published: (2019-07-01)

Predictors of non-alcoholic fatty liver disease in obese and overweight Egyptian children: Single center study
by: Hanaa M El-Karaksy, et al.
Published: (2011-01-01)

Bicyclol attenuates high fat diet-induced non-alcoholic fatty liver disease/non-alcoholic steatohepatitis through modulating multiple pathways in mice
by: Jingyi Wu, et al.
Published: (2023-03-01)

Endothelial dysfunction and cardiovascular risk in non-alcoholic fatty liver disease – a systematic review and meta-analysis
by: Nilesh Toke, et al.
Published: (2024-05-01)

Erratum: Bicyclol attenuates high fat diet-induced non-alcoholic fatty liver disease/non-alcoholic steatohepatitis through modulating multiple pathways in mice
by: Frontiers Production Office
Published: (2023-04-01)